Pieris Pharmaceuticals Inc (PIRS)
15.87
-0.08
(-0.52%)
USD |
NASDAQ |
Nov 15, 16:00
15.68
-0.19
(-1.18%)
After-Hours: 20:00
Pieris Pharmaceuticals Research and Development Expense (TTM): 16.02M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 16.02M |
| March 31, 2024 | 29.60M |
| December 31, 2023 | 41.80M |
| September 30, 2023 | 50.73M |
| June 30, 2023 | 54.72M |
| March 31, 2023 | 52.34M |
| December 31, 2022 | 52.98M |
| September 30, 2022 | 54.96M |
| June 30, 2022 | 60.31M |
| March 31, 2022 | 64.16M |
| December 31, 2021 | 66.66M |
| September 30, 2021 | 61.92M |
| June 30, 2021 | 54.80M |
| March 31, 2021 | 50.34M |
| December 31, 2020 | 46.53M |
| September 30, 2020 | 50.03M |
| June 30, 2020 | 51.42M |
| March 31, 2020 | 53.46M |
| Date | Value |
|---|---|
| December 31, 2019 | 55.00M |
| September 30, 2019 | 53.88M |
| June 30, 2019 | 52.07M |
| March 31, 2019 | 47.85M |
| December 31, 2018 | 41.49M |
| September 30, 2018 | 33.76M |
| June 30, 2018 | 28.62M |
| March 31, 2018 | 24.86M |
| December 31, 2017 | 22.28M |
| September 30, 2017 | 23.93M |
| June 30, 2017 | 22.30M |
| March 31, 2017 | 21.40M |
| December 31, 2016 | 19.70M |
| September 30, 2016 | 15.72M |
| June 30, 2016 | 13.15M |
| March 31, 2016 | 10.38M |
| December 31, 2015 | 8.245M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
16.02M
Minimum
Jun 2024
66.66M
Maximum
Dec 2021
50.93M
Average
52.98M
Median
Dec 2022
Research and Development Expense (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | 22.49M |
| NovaBay Pharmaceuticals Inc | 0.064M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.61M |